iridium radioisotopes has been researched along with Cystadenocarcinoma, Papillary in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altobelli, K; Angel, C; DuBeshter, B; Estler, K; Glantz, C; McDonald, S | 1 |
1 other study(ies) available for iridium radioisotopes and Cystadenocarcinoma, Papillary
| Article | Year |
|---|---|
High-dose rate brachytherapy for Stage I/II papillary serous or clear cell endometrial cancer.
Topics: Adenocarcinoma, Clear Cell; Aged; Brachytherapy; Cystadenocarcinoma, Papillary; Cystadenocarcinoma, Serous; Disease-Free Survival; Dose-Response Relationship, Radiation; Endometrial Neoplasms; Female; Humans; Iridium Radioisotopes; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Retrospective Studies | 2004 |